ATE438723T1 - Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren - Google Patents

Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren

Info

Publication number
ATE438723T1
ATE438723T1 AT00112074T AT00112074T ATE438723T1 AT E438723 T1 ATE438723 T1 AT E438723T1 AT 00112074 T AT00112074 T AT 00112074T AT 00112074 T AT00112074 T AT 00112074T AT E438723 T1 ATE438723 T1 AT E438723T1
Authority
AT
Austria
Prior art keywords
cyclic gmp
methods
specific phosphodiesterase
binding
materials
Prior art date
Application number
AT00112074T
Other languages
English (en)
Inventor
Joseph Beavo
Jackie D Corbin
Kenneth Ferguson
Sharron H Francis
Ann Kadlecek
Kate Loughney
Linda Mcallister-Lucas
William Sonnenburg
Melissa Thomas
Original Assignee
Univ Washington
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22080121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE438723(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington, Icos Corp filed Critical Univ Washington
Application granted granted Critical
Publication of ATE438723T1 publication Critical patent/ATE438723T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00112074T 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren ATE438723T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6805193A 1993-05-27 1993-05-27

Publications (1)

Publication Number Publication Date
ATE438723T1 true ATE438723T1 (de) 2009-08-15

Family

ID=22080121

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94919288T ATE199569T1 (de) 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren.
AT00112074T ATE438723T1 (de) 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94919288T ATE199569T1 (de) 1993-05-27 1994-05-27 Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren.

Country Status (12)

Country Link
US (7) US5702936A (de)
EP (2) EP0652960B9 (de)
JP (3) JP4150070B2 (de)
AT (2) ATE199569T1 (de)
CA (3) CA2698716A1 (de)
DE (3) DE69426804T4 (de)
DK (2) DK0652960T3 (de)
ES (2) ES2156898T3 (de)
GR (1) GR3035616T3 (de)
LV (1) LV12814B (de)
PT (2) PT1038963E (de)
WO (1) WO1994028144A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222647A1 (en) * 1993-05-27 2006-10-05 Beavo Joseph A Methods and compositions for modulating the activity of PDE5
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
AU3307999A (en) * 1998-02-23 1999-09-06 Icos Corporation Phosphodiesterase 10
EP1101821A4 (de) * 1998-07-21 2002-05-08 Takeda Chemical Industries Ltd Neues protein und seine dna
AU1833000A (en) * 1998-11-25 2000-06-19 Cell Pathways, Inc. Method for diagnosing neoplasia
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6100037A (en) * 1999-01-07 2000-08-08 Incyte Pharmaceuticals, Inc. Human cyclic nucleotide PDEs
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
US6146876A (en) * 1999-06-11 2000-11-14 Millennium Pharmaceuticals, Inc. 22025, a novel human cyclic nucleotide phosphodiesterase
US7098015B2 (en) * 1999-06-11 2006-08-29 Millennium Pharmaceuticals, Inc. 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
CN1297049A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
US20020006926A1 (en) 2000-04-19 2002-01-17 Roylance H. H. Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of parkinson's disease
US6794192B2 (en) 2000-06-29 2004-09-21 Pfizer Inc. Target
GB0016009D0 (en) * 2000-06-29 2000-08-23 Pfizer Ltd Target
US20030096864A1 (en) * 2000-06-30 2003-05-22 Fang Lawrence Y. Compounds to treat alzheimer's disease
US6846813B2 (en) * 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
EP1317564B1 (de) * 2000-09-14 2007-08-01 Mount Sinai School of Medicine Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
EP1572871A4 (de) * 2001-04-20 2007-11-14 Sinai School Medicine T1r3, ein neuer geschmacksrezeptor
US20070213407A1 (en) * 2001-06-29 2007-09-13 Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc Compounds to treat Alzheimer's disease
EP1414841B1 (de) 2001-07-10 2012-11-14 Lakewood-Amedex, Inc Oligonukleotidhaltige pharmakologische zusammensetzungen und deren verwendung
US20050202549A1 (en) * 2001-11-02 2005-09-15 Pfizer Inc Crystal structure
GB0126417D0 (en) * 2001-11-02 2002-01-02 Pfizer Ltd Crystal structure
US7304128B2 (en) * 2002-06-04 2007-12-04 E.I. Du Pont De Nemours And Company Carbon nanotube binding peptides
BRPI0409931A (pt) * 2003-05-01 2006-04-25 Pfizer cristal de pde5, sua estrutura de cristal e seu em projeto de droga
JP2010004758A (ja) * 2008-06-24 2010-01-14 Probex Inc ｃｙｃｌｉｃＧＭＰ検出方法
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
KR101550217B1 (ko) * 2014-03-26 2015-09-04 전남대학교산학협력단 숙주세포의 생체 회로 간섭 없이 외래 유전자를 발현하기 위한 재조합 벡터 및 이의 용도
JP6885595B2 (ja) * 2015-12-04 2021-06-16 国立大学法人 東京大学 リガンド蛍光センサータンパク質とその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1290210B (de) * 1962-12-04 1969-03-06 Siemens Ag Vorrichtung zum maschinellen Verlegen und Anschliessen von Schaltdraehten
US4129349A (en) * 1975-11-10 1978-12-12 Bell Telephone Laboratories, Incorporated Quick-connect breadboarding system
JPH0797015B2 (ja) * 1988-10-28 1995-10-18 株式会社ピーエフユー 画像処理によるｓｍｄの位置補正方式
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
JPH038400A (ja) * 1989-06-06 1991-01-16 Sharp Corp プリント基板の位置補正方法
US5015637A (en) * 1990-05-25 1991-05-14 Hoechst-Roussel Pharmaceutical Inc. Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines
ATE250629T1 (de) * 1991-04-19 2003-10-15 Univ Washington Für säugetierphosphodiesterasen kodierende dns
WO1993005182A1 (en) * 1991-09-05 1993-03-18 Isis Pharmaceuticals, Inc. Determination of oligonucleotides for therapeutics, diagnostics and research reagents
US6403302B1 (en) * 1992-09-17 2002-06-11 California Institute Of Technology Methods and compositions for triple helix formation

Also Published As

Publication number Publication date
LV12814B (lv) 2002-10-20
CA2141060A1 (en) 1994-12-08
ES2333691T3 (es) 2010-02-26
DE69426804T4 (de) 2005-10-13
DK0652960T3 (da) 2001-04-17
DK1038963T3 (da) 2009-11-23
EP0652960B1 (de) 2001-03-07
EP1038963A2 (de) 2000-09-27
HK1013427A1 (en) 1999-08-27
US5702936A (en) 1997-12-30
WO1994028144A1 (en) 1994-12-08
ES2156898T3 (es) 2001-08-01
ATE199569T1 (de) 2001-03-15
LV12814A (en) 2002-04-20
EP1038963A3 (de) 2000-10-04
JP2010042035A (ja) 2010-02-25
CA2698716A1 (en) 1994-12-08
DE69426804T2 (de) 2001-07-19
EP0652960B9 (de) 2004-10-27
CA2363537A1 (en) 1994-12-08
CA2363537C (en) 2010-07-06
DE69426804D1 (de) 2001-04-12
JP4150070B2 (ja) 2008-09-17
DE69435227D1 (de) 2009-09-17
EP0652960A1 (de) 1995-05-17
US5955583A (en) 1999-09-21
US20030054992A1 (en) 2003-03-20
US6037119A (en) 2000-03-14
JPH08502900A (ja) 1996-04-02
US5652131A (en) 1997-07-29
JP4450767B2 (ja) 2010-04-14
JP2005245467A (ja) 2005-09-15
CA2141060C (en) 2002-02-19
PT1038963E (pt) 2009-10-13
GR3035616T3 (en) 2001-06-29
PT652960E (pt) 2001-08-30
US20050196833A1 (en) 2005-09-08
EP1038963B1 (de) 2009-08-05
US20060216809A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
ATE438723T1 (de) Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren
DK0535216T3 (da) DNA. der koder mammale phosphodiesteraser
ATE315643T1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
ATE376590T1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
PT85237A (en) Process for the preparation of alkylnylamino-nucleotides
IL195812A0 (en) Human tslp dna and polypeptides
ATE522610T1 (de) Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen
WO1995006735A3 (en) Nucleotide sequences for novel protein tyrosine phosphatases
NZ315514A (en) Tumour necrosis factor associated factor (traf) inhibitors including traf polypeptide, murine nucleotide sequence and associated assays
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
EP0546087A4 (de)
EP0897011A3 (de) Arginin Deiminase
HU9204037D0 (en) Recombinant dna molecules coding activity of bacillus p-nitrobenzyl esterase and expression vectors thereof
EP1241186A3 (de) Menschliches gas-6 (growth arrest-specific gene 6) Protein und dafür kodierende Nukleinsäure
EP0913479A3 (de) Adenin Glycosylase
WO2002077220A3 (en) Nucleic acids encoding human est1 proteins
DE69827532D1 (de) Polypeptide und dafür kodierende Nukleinsäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1038963

Country of ref document: EP

REN Ceased due to non-payment of the annual fee